(Total Views: 248)
Posted On: 09/13/2019 3:20:43 PM
Post# of 108086

$AMGN News Article - Amgen Announces Phase 3 CANDOR Study Combining KYPROLIS (carfilzomib) And DARZALEX (daratumumab) Meets Primary Endpoint Of Progression-Free Survival https://marketwirenews.com/news-releases/amge...87700.html


My Twitter: WhyteStocks